Adrixetinib

Cat. No. M29591

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Adrixetinib is an inhibitor of protein tyrosine kinase with antineoplastic activity.

Molecular Weight	531.48
Formula	C25H24F3N5O5
CAS Number	2394874-66-7
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.

Related c-Met Products
Zurletrectinib Zurletrectinib (ICP-723) is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib can used for research of TRK-mediated related diseases.
ABN401 ABN401 is a highly potent and selective ATP-competitive c-MET inhibitor with an IC50 value of 10 nM.
(Z)-Semaxanib (Z)-Semaxanib is a potent tyrosine kinase inhibitor.
MET kinase-IN-2 MET kinase-IN-2 is a potent, selective, orally bioavailable MET kinase inhibitor with an IC50 of 7.4 nM.
BMS-817378 BMS-817378 is a potent and selective inhibitor of MET with IC50 of 1.7 nM.

Catalog